Histogenesis of Kaposi's sarcoma and angiosarcoma of the face and the scalp.
This study reviews data on the histogenesis of Kaposi's sarcoma and angiosarcoma derived from clinical features, histology, electron microscopy, enzyme histochemistry, and immunochemistry of both diseases. Their hemorrhagic clinical appearance contrasts the predominantly lymphatic histologic features of vessels in early lesions. Investigations performed to resolve the debate whether these tumors arise from blood vessel or lymphatic endothelium show remarkably similar results for both conditions. Electron microscopy reveals Weibel - Palade bodies in a minority of cases, but features consistent with less well-differentiated blood vessel endothelium may be seen in a greater proportion of tumors. Enzyme histochemistry generally shows absence of adenosine triphosphatase and alkaline phosphatase in tumor cells; a pattern of enzymes similar to that found in normal lymphatic endothelium. Conflicting data arises from the large number of immunohistochemical studies performed on both conditions. Factor VIII-related antigen and Ulex europaeus agglutinin-I have been most frequently employed, but the specificity of these agents for blood vessel endothelium is debatable. Panendothelial markers show consistent labeling of both tumors, but marker studies employing a wide range of monoclonal antibodies specific for blood vessel endothelium have shown occasional positive labeling of tumor cells. A number of studies have claimed absence of labeling with specific blood vessel monoclonal antibodies, but at present no study employing a specific marker for lymphatic endothelium has been reported. Although the demonstration of specific markers for blood vessel endothelium in these tumors has been variable, the data would be compatible with lesions arising from undifferentiated stem cells that proliferate with varying degrees of differentiation toward blood vessel endothelium. An alternative hypothesis for the histogenesis of Kaposi's sarcoma would be one of multicentric hyperplasia containing lymphatic venular anastamoses with elements of both lymphatic and blood vessel endothelium.
Holden
C A
CA
Skin Laboratory, St Helier Hospital, Carshalton, Surrey, U.K.
D000911:Antibodies, Monoclonal / Q000276:immunology; D000941:Antigens / Q000032:analysis; D001485:Basement Membrane / Q000032:analysis; D004730:Endothelium, Vascular / Q000166:cytology / Q000276:immunology; D005153:Facial Neoplasms / Q000378:metabolism / Q000473:pathology*; D005167:Factor VII / Q000032:analysis / Q000276:immunology; D006394:Hemangiosarcoma / Q000378:metabolism / Q000473:pathology*; D006651:Histocytochemistry; D006801:Humans; D007150:Immunohistochemistry; D037102:Lectins; D037121:Plant Lectins; D012514:Sarcoma, Kaposi / Q000378:metabolism / Q000473:pathology*; D012535:Scalp; D012878:Skin Neoplasms / Q000378:metabolism / Q000473:pathology*; D014841:von Willebrand Factor / Q000032:analysis
D000911:Antibodies, Monoclonal; D000941:Antigens; D037102:Lectins; D037121:Plant Lectins; C036850:Ulex europaeus lectins; C031500:factor VII related antigen; D014841:von Willebrand Factor; D005167:Factor VII